Gamma Technologies acquires ProFEMAG portfolio
The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based in the US State of Illinois is now planning to establish a Global Center of Excellence for electrical machines in Basel.
Gamma Technologies (GT) is acquiring the FEMAG software portfolio. FEMAG is an electromagnetic simulation solution for electrical machines based on the physical finite element method. It has been continually further developed and enhanced by ProFEMAG AG and Semafor Informatik und Energie AG, which are both based in Basel. The project was first launched at the Institute of Electrical Machines at the Swiss Federal Institute of Technology in Zurich (ETH) in 1982.
FEMAG technologies have been integrated in the GT-SUITE system simulation platform from Gamma Technologies. They facilitate “a complete design solution for batteries, electric drives and power electronics”, explains Dimple Shah, GT President and CEO, in a press release issued by his company.
Global Center of Excellence in Basel
“The tight integration of our solutions into the GT-SUITE system simulation platform has opened new possibilities for the engineering community”, comments Walter Egli, CEO of ProFEMAG, in the press release, before adding that GT’s culture of innovation “provides an excellent home for FEMAG technologies and people”. According to Dr. Ronald Tanner, CTO of Semafor, this “next chapter with GT” will enable the company “to accelerate the pace of development”.
For future cooperation with ProFEMAG and Semafor, GT plans to set up a Global Center of Excellence in Basel. This will be an innovation hub for the research, development and deployment of multiphysics simulation technologies for the next generation of high-efficiency electric machine applications. The investment and innovation promotion agency Basel Area Business & Innovation will be supporting this project.
Share this article
You may also be interested in
VectivBio sold for approximately 1 billion dollars
The takeover of VectivBio is now being finalized: the Boston-based firm Ironwood Pharmaceuticals, which specializes in gastrointestinal medicine, has agreed...Read More
University of Basel and RocketVax present new Covid vaccine
Researchers from the University of Basel have developed a new concept for a Covid vaccine in collaboration with the biotech...Read More
Rami Swiss and Elbit Systems now manufacturing in Jura
The newly established company Rami Swiss has inaugurated a new production facility in Courtételle in the canton of Jura together...Read More
Basel to become Europe’s Silicon Valley of biotech
Silicon Valley is synonymous with technology and innovation, and home to dozens of Fortune 1000 companies and thousands of startups....Read More
Roche and Novartis among global leaders for research spending
In 2022, Roche invested 16 billion euros in research and development overall. This puts the Basel-based life sciences firm in...Read More
Roche to found Institute for Human Biology
Roche has announced that it will be establishing the Institute of Human Biology in Basel. Up to 250 employees will...Read More